TAK EPS Estimates
Takeda Pharmaceutical Company Limited
$20.85
-$0.24(-1.14%)
63
Overall
60
Value
75
Tech
55
Quality
Market Cap
$66.64B
Volume
1.70M
52W Range
$13.56 - $21.73
Target Price
$22.63
TAK EPS estimates: the consensus estimate for Takeda Pharmaceutical Company Limited's current fiscal year is $1.56 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
TAK EPS Estimates
- EPS estimate, current quarter
- $0.45
- EPS estimate, next quarter
- $0.28
- EPS estimate, current year
- $1.56
- EPS estimate, next year
- $1.40
- EPS growth, 3-year
- -13.84%
| Fiscal year | EPS |
|---|---|
| 2026 | $34.18 |
| 2025 | $17.09 |
| 2024 | $46.04 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TAK | $20.85 | -1.1% | 1.70M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Takeda Pharmaceutical Company Limited Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW